NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

LessIsMore,

Yes, that whole quote points toward her belief that crossover patients are receiving some benefit which is exactly what my early research suggested DC vaccination at recurrence could do, not on it's own but with salvage therapy. That benefit was measured by some studies as being up to 2 months. So guess why the trial is taking so long. Good guess! They are separating out the differences seen between early treatment benefit from later crossover treatment benefit and any other benefit derived from the European side of things. Thank you for reminding us all of the need for this time extension. Best wishes.